The program, which began in 2013 with just seven screenings, has now conducted over 50,000 screenings. Dr. Gieske shared the impact of these efforts: "We've now found over 500 stage 1 lung cancers ...

Lung cancer is not rare. It was the most common cancer diagnosis in 2022—and the deadliest, according to the International Agency for Research on Cancer. Despite its frequency, there are still ...

Nearly a quarter of all newly diagnosed patients with advanced lung cancer are not given a test that could improve their chances for long-term survival and reduce their side effects.